An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

BACKGROUND. No laboratory test can predict the risk of nonrelapse mortality (NRM) or severe graft-versus-host disease (GVHD) after hematopoietic cellular transplantation (HCT) prior to the onset of GVHD symptoms. METHODS. Patient blood samples on day 7 after HCT were obtained from a multicenter set...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:JCI Insight
Κύριοι συγγραφείς: Hartwell, Matthew J., Özbek, Umut, Holler, Ernst, Renteria, Anne S., Major-Monfried, Hannah, Reddy, Pavan, Aziz, Mina, Hogan, William J., Ayuk, Francis, Efebera, Yvonne A., Hexner, Elizabeth O., Bunworasate, Udomsak, Qayed, Muna, Ordemann, Rainer, Wölfl, Matthias, Mielke, Stephan, Pawarode, Attaphol, Chen, Yi-Bin, Devine, Steven, Harris, Andrew C., Jagasia, Madan, Kitko, Carrie L., Litzow, Mark R., Kröger, Nicolaus, Locatelli, Franco, Morales, George, Nakamura, Ryotaro, Reshef, Ran, Rösler, Wolf, Weber, Daniela, Wudhikarn, Kitsada, Yanik, Gregory A., Levine, John E., Ferrara, James L.M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Clinical Investigation 2017
Θέματα:
Clinical Medicine
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291735/
https://ncbi.nlm.nih.gov/pubmed/28194439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89798
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια